Lian Li
Impact in
- Immunology top 5%
- Immune cells in cancer
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Psoriasis: Treatment and Pathogenesis
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Immune cells in cancer 4
- Immunotherapy and Immune Responses 3
- T-cell and B-cell Immunology 2
- Oncology 6
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Limin Zheng (13 shared papers)Yi Zhang (1 shared paper)Jing Liang (1 shared paper)Jing Yan (1 shared paper)Jing‐Ping Zhang (1 shared paper)Yan Wu (2 shared papers)Xing-Juan Yu (3 shared papers)Hui‐Lan Rao (2 shared papers)
- Journals
- PLoS ONE (2 papers)The Journal of Pathology (1 paper)Frontiers in Nutrition (1 paper)Annals of Surgical Oncology (1 paper)Cancer Science (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Lian Li
17 papers receiving 924 citations
Peers
Comparison fields: 5 of 58
- Immunology 361
- Hepatology 136
- Oncology 336
- Pharmacology 35
- Pharmacology 43
Countries citing papers authored by Lian Li
This map shows the geographic impact of Lian Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lian Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lian Li more than expected).
Fields of papers citing papers by Lian Li
This network shows the impact of papers produced by Lian Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lian Li. The network helps show where Lian Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Lian Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 171 | |
| 2 | 2010 | 136 | |
| 3 | 2011 | 97 | |
| 4 | 2013 | 68 | |
| 5 | 2013 | 65 | |
| 6 | 2020 | 65 | |
| 7 | 2012 | 63 | |
| 8 | 2021 | 63 | |
| 9 | 2016 | 61 | |
| 10 | 2015 | 58 | |
| 11 | 2007 | 30 | |
| 12 | 2016 | 28 | |
| 13 | 2020 | 13 | |
| 14 | 2021 | 6 | |
| 15 | 2025 | 6 | |
| 16 | 2009 | 4 | |
| 17 | 2025 | 2 |
About Lian Li
Lian Li is a scholar working on Immunology, Oncology, Pharmacology, Hepatology and Pharmacology, having authored 17 papers that have together received 936 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Immune cells in cancer (4 papers), Fungal Biology and Applications (3 papers), Immunotherapy and Immune Responses (3 papers), Medicinal Plant Pharmacodynamics Research (2 papers), T-cell and B-cell Immunology (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Endoplasmic Reticulum Stress and Disease (1 paper). The work is most often cited by research in Immunology (361 citations), Hepatology (136 citations), Oncology (336 citations), Pharmacology (35 citations) and Pharmacology (43 citations). Lian Li has collaborated with scholars based in China and United States. Frequent co-authors include Limin Zheng, Yi Zhang, Jing Liang, Jing Yan, Jing‐Ping Zhang, Yan Wu, Xing-Juan Yu, Hui‐Lan Rao, Yi Zhang and Dong‐Ming Kuang. Their work appears in journals such as PLoS ONE, The Journal of Pathology, Frontiers in Nutrition, Annals of Surgical Oncology and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.